Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FX29M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,469
Award facts
- Contract value 100% obligated
- $2,468.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,468.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on August 12, 2025, with an ultimate completion date of August 13, 2025. This is an unset-aside, competitively awarded contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Mounjaro is a diabetes medication used for blood sugar management, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products delivered through the DLA Medical Supply Chain. As a major pharmaceutical distributor, AmerisourceBergen supplies brand-name and generic medications, vaccines, and specialized medical devices to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order represents one of numerous small to moderate value transactions executed under the company's prime indefinite delivery vehicle, demonstrating its capability to fulfill federal medical procurement requirements across diverse therapeutic domains and customer bases within the Department of Defense healthcare ecosystem.
Quick answers
Who was awarded contract SPE2DB25FX29M?
SPE2DB25FX29M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FX29M worth?
The government has obligated $2,469 on SPE2DB25FX29M.
Is contract SPE2DB25FX29M an order under another contract?
Yes. SPE2DB25FX29M is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX29M competed?
The extent of competition for SPE2DB25FX29M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award